Overview
Bogi Andersen is an Endocrinologist in Orange, California. Dr. Andersen is rated as an Experienced provider by MediFind in the treatment of Glucocorticoid Resistance. His top areas of expertise are Hashimoto Thyroiditis, Triple A Syndrome, Type 2 Diabetes (T2D), and Addison's Disease.
His clinical research consists of co-authoring 58 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 The City Dr S, Uci Dept Of Medicine, Orange, CA 92868
Additional Areas of Focus
Dr. Andersen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Uc Regents
Almoatazbellah Idriss is an Endocrinologist in Orange, California. Dr. Idriss is rated as a Distinguished provider by MediFind in the treatment of Glucocorticoid Resistance. His top areas of expertise are Prolactinoma, Triple A Syndrome, Glucocorticoid Resistance, and Familial Glucocorticoid Deficiency.
Providence Medical Institute
Lubna Naqi is an Endocrinologist in Torrance, California. Dr. Naqi is rated as an Advanced provider by MediFind in the treatment of Glucocorticoid Resistance. Her top areas of expertise are Triple A Syndrome, Thyroid Nodule, Hypoaldosteronism, and Glucocorticoid Resistance.
City Of Hope Medical Foundation
Raynald Samoa is an Endocrinologist and a Pediatrics provider in Duarte, California. Dr. Samoa is rated as a Distinguished provider by MediFind in the treatment of Glucocorticoid Resistance. His top areas of expertise are Type 2 Diabetes (T2D), Thyroid Cancer, Follicular Thyroid Cancer, and Medullary Thyroid Carcinoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Addison's DiseaseDr. Andersen isExperienced. Learn about Addison's Disease.
- Anaplastic Thyroid CancerDr. Andersen isExperienced. Learn about Anaplastic Thyroid Cancer.
- Ballinger-Wallace SyndromeDr. Andersen isExperienced. Learn about Ballinger-Wallace Syndrome.
- Exogenous Cushing's syndromeDr. Andersen isExperienced. Learn about Exogenous Cushing's syndrome.
- Familial Glucocorticoid DeficiencyDr. Andersen isExperienced. Learn about Familial Glucocorticoid Deficiency.
- Familial Hypocalciuric Hypercalcemia Type 1Dr. Andersen isExperienced. Learn about Familial Hypocalciuric Hypercalcemia Type 1.